Comorbidity and aging with HIV


The main goals of this project are:
1) To develop a screening protocol for HIV related co-morbidities and their risk factors through multi disciplinary expert consultation;
2) To implement this screening protocol in the setting of a large HIV outpatient clinic;
3) To assess the prevalence and incidence of co-morbidity and organ system dysfunction in the setting of HIV infection and to evaluate whether the burden is increased compared to a comparable group of HIV-uninfected healthy individuals; and
4) To compare quality of life for patients both with and without co-morbidity, who are HIV-infected or HIV-uninfected.


Use of combination antiretroviral therapy (cART) has resulted in a major decline of HIV-related morbidity and mortality. As a result, the life expectancy of patients with HIV has increased. Unfortunately, this major success of cART does come at a cost. Several studies have demonstrated an increased incidence of heart disease, diabetes mellitus, kidney disease, liver disease, osteoporosis, malignancies, and possibly chronic obstructive pulmonary disease in HIV-infected individuals when compared to in age matched HIV-uninfected controls. There is increasing evidence that, over and above the effects of age, both HIV-related factors and the adverse effects of cART also independently contribute to the risk.


In this project one of the main aims is to assess the incidence and prevalence of a broad range of co-morbidities and known risk factors for these co-morbidities in HIV-infected patients using a number of complimentary approaches.

AIGHD Research Lead

Prof. Peter Reiss


Amsterdam University Medical Center (Amsterdam UMC)

Municipal Health Service Amsterdam. HIV/STD Research Infectious Diseases Department

Stichting HIV Monitoring

Contact info

Lilly Dol (


ZonMw and Industry